×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
After saving Yumanity's assets, Kineta faces shutdown as private placement fails to show up
Fierce Biotech
After saving Yumanity's assets, Kineta faces shutdown as private placement fails to show up ... In 2022, Kineta swooped in to rescue Yumanity's...
2 months ago
Seattle biotech company Kineta lays off majority of staff, including its CEO
GeekWire
Kineta announced Thursday that it is laying off 64% of its workforce, or seven employees — including its CEO Shawn Iadonato — as it...
2 months ago
C-Suite Shuffle: Sumitomo, Kineta, IDRx and More
BioSpace
C-Suite Shuffle: Sumitomo, Kineta, IDRx and More ... Welcome to the second in a regular series of rundowns of people coming and going from...
2 months ago
Kineta Restructures To Prioritize Cash, Explores Strategic Options
Contract Pharma
Kineta Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune...
2 months ago
Kineta Shares Plunge on CEO Exit, Other Layoffs As It Explores Strategic Options
MarketWatch
By Sabela Ojea Shares of Kineta on Thursday plunged after the company said it is letting go Chief Executive Shawn Iadonato as it mulls...
2 months ago
Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc
Yahoo Finance
On September 14, 2023, Thierry Guillaudeux, the Chief Scientific Officer of Kineta Inc (NASDAQ:KA), made a significant insider purchase of...
7 months ago
Kineta CEO included in biotech's latest round of layoffs - Puget Sound Business Journal
The Business Journals
Kineta's CEO says the funding that was expected to arrive in April will not materialize.
2 months ago
Kineta Reports Progress in KVA12123 Cancer Trial - TipRanks.com
Tipranks
Kineta, Inc. has shared exciting news in their latest press release about the progress of their VISTA-101 Phase 1/2 clinical trial. Their innovative...
1 month ago
Kineta (NASDAQ:KA) Stock Price Down 7.4%
Defense World
Kineta, Inc. (NASDAQ:KA – Get Free Report)'s share price fell 7.4% during mid-day trading on Wednesday . The company traded as low as $0.60...
3 weeks ago
KA Stock Quote Price and Forecast
CNN
View Kineta, Inc. KA stock quote prices, financial information, real-time forecasts, and company news from CNN.
2 months ago